BioCentury | Feb 13, 2021
New venture partners at SR One; plus moves at Surface Oncology, Agenus, AbCellera, BioDelivery, Transcenta, Dewpoint, Cortexyme, Cerevance and Penrose
SR One named Chris Chai and Peter Van Vlasselaer venture partners. Chai was CFO of Principia Biopharma Inc., which Sanofi (Euronext:SAN; NASDAQ:SNY) acquired last year for $3.4 billion. Van Vlasselaer was most recently founder, president, and CEO...